Cancer Immunology – News and Features

This is the first demonstration of T-cell culture in a microfluidic chip the size of a pack of cards, allowing the miniaturisation of CAR T-cell production for cancer treatment.

Researchers at Lund University have designed a hybrid antibody that better stimulates the immune system against both the SARS-CoV-2 virus and streptococcal bacteria.

Patented method developed in the laboratory of Dr Sandro Ataide promises to accelerate the potential of genetic engineering already shown by CRISPR gene-editing technology.

Researchers have developed a solution to retain the naïve state of cells in adoptive T-cell therapy, allowing them to be even better disease fighters when they are infused back into a patient.

Scripps Research scientists found that a “one-two punch” of combining the immunosuppressive drug ruxolitinib with existing checkpoint inhibitor therapies may be a more effective way to fight some cancers, including Hodgkin lymphoma.

Results from a new trial indicate that immunotherapy could successfully be used to treat the most common form of colorectal cancer.

Periods of fasting reprogram the immune system’s natural killer cells to better fight cancer, according to a new study in mice from researchers at Memorial Sloan Kettering Cancer Center (MSK).

An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a study led by researchers at Weill Cornell Medicine.

Researchers at The Jackson Laboratory have not only identified how two immune cells work together to fight cancer but also revealed the cascade of molecules that help coordinate this attack.

New research illustrates that the risk of secondary cancers following CAR T-cell therapy is low.